T2 Biosystems Joins Antimicrobials Working Group as First Diagnostic Member
Jul 27, 2017 12:58 pm UTC| Business
LEXINGTON, Mass., July 27, 2017 -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced today that it will join the...
Corporate Capital Trust II Invests in First Originated Transaction
Jul 27, 2017 12:57 pm UTC| Business
Orlando, Fla., July 27, 2017 -- Corporate Capital Trust II, a business development company that offers individuals the unique opportunity to invest in the debt of privately owned American companies, recently closed...
Opiant CEO Roger Crystal Appears on Fox & Friends
Jul 27, 2017 12:44 pm UTC| Business
SANTA MONICA, Calif., July 27, 2017 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and eating disorders, today announced...
Jul 27, 2017 12:31 pm UTC| Business
SAN FRANCISCO, July 27, 2017 -- Global Armored Vehicle Market Report by Variant Market Research, estimate that global market is projected to reach $39 Billion by 2024, from $26 billion in 2016. The report will include...
The Association of Zoos and Aquariums Announces Two New Animal Management Center Directors
Jul 27, 2017 12:31 pm UTC| Business
Silver Spring, MD, July 27, 2017 -- The Association of Zoos and Aquariums (AZA) is pleased to announce Kristine Schad as the new director of the AZA Population Management Center (PMC) located at Lincoln Park Zoo. ...
Donuts Completes Successful Tender Offer for Shares of Rightside
Jul 27, 2017 12:31 pm UTC| Business
KIRKLAND, Wash., July 27, 2017 -- Rightside Group, Ltd. (NASDAQ:NAME) (“Rightside”) and Donuts Inc. (“Donuts”) today announced that DTS Sub Inc. (“Purchaser”), a wholly owned subsidiary of Donuts, has successfully...
Neuralstem Announces Pricing of Public Offering of Common Stock and Warrants
Jul 27, 2017 12:30 pm UTC| Business
GERMANTOWN, Md., July 27, 2017 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced the pricing of an underwritten public offering of...